| Literature DB >> 24441055 |
Kun Hyung Kim1, Jung Won Kang, Myeong Soo Lee, Jae-Dong Lee.
Abstract
OBJECTIVES: High-quality reporting of treatment details can aid replication of study results in real-world clinical practice. The Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) is a reporting guideline for key elements of acupuncture interventions in clinical trials. This study used STRICTA to investigate whether Cochrane reviews of acupuncture adequately report important treatment details.Entities:
Keywords: Complementary Medicine; Medical Education & Training; Statistics & Research Methods
Mesh:
Year: 2014 PMID: 24441055 PMCID: PMC3902460 DOI: 10.1136/bmjopen-2013-004136
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Response of review authors for the reporting of acupuncture details in the Cochrane review
| N=25 | Q1 (%) | Q2 (%) | Q3 (%) | Q4 (%) |
|---|---|---|---|---|
| Yes | 11 (44) | 4 (16) | 0 (0) | 0 (0) |
| No | 2 (8) | 5 (20) | 10 (40) | 8 (32) |
| No answer | 12 (48) | 16 (64) | 15 (60) | 17 (68) |
Q1. Are you aware of any guideline or recommendation for reporting details of acupuncture treatment in journal publication?
Q2. Have you ever referred or used any reporting guidelines or recommendations when you reported the details of acupuncture treatments in your Cochrane review?
Q3. Have you ever received any guideline or recommendation for reporting details of acupuncture treatment from the Cochrane review group, when writing or updating your review?
Q4. Have you ever received any constraints or restrictions when reporting the details of acupuncture treatments in your Cochrane review?
Figure 1Flowchart of Cochrane reviews and component study selections. CDSR; Cochrane Database of Systematic Reviews.
General characteristics of Cochrane reviews related to acupuncture
| Included Cochrane reviews N=25 | |
|---|---|
| Number of Cochrane reviews, N (%) | |
| Acupuncture as primary | 17 |
| Acupuncture as secondary | 8 |
| Number of component study | |
| Total | 409 |
| Mean | 16.36 (11.77) |
| Median (Q1–Q3) | 13 (3–47) |
| Number of component study published after 2005 | |
| Total | 92 |
| Mean | 3.7 (3.85) |
| Median (Q1–Q3) | 2 (1–5) |
| Publication language of component studies after 2005, N (%) | |
| Total | 92 |
| English | 58 (63) |
| Languages other than English | 34 (37) |
| Number of component studies published in | |
| Acupuncture-related journal | 47 |
| Western medicine journal | 43 |
| Publication year | |
| Cochrane review (Q1–Q3) | 2010 (2008–2011) |
| Component studies (Q1–Q3) | 2007 (2006–2008) |
| Types of control*, N (%) | |
| Sham acupuncture | 34 (37) |
| Active acupuncture | 14 (15) |
| Non-acupuncture | 68 (74) |
| Clinical heterogeneity related to acupuncture | |
| Investigated | 12 (48%) |
| in subgroup analysis | 5 (20%) |
| in sensitivity analysis | 6 (24%) |
| in other analysis | 8 (32%) |
| Not investigated | 13 (52%) |
*Sum of the number of each control group may exceed the total number of included trials, since there are trials that have more than two control groups.
Q1–Q3: IQR 1–3.
Figure 2The number of reported items of STRICTA in Cochrane reviews of acupuncture and related RCTs. RCT, randomised controlled trial.
The number of component studies in Cochrane reviews and of original RCTs with reporting of selected STRICTA items
| Items | Component studies in Cochrane reviews | Original RCTs | Difference (95% CI)* | ||
|---|---|---|---|---|---|
| n/N | (%) | n/N | (%) | ||
| A. Acupuncture rationale | |||||
| (1) Style of acupuncture treatment | 59/92 | (64.1) | 66/92 | (71.7) | 7.6 (1.1 to 14.1) |
| (2) Reasoning of treatment | 6/92 | (6.5) | 42/92 | (45.6) | 39.1 (28.1 to 50.2) |
| (3) Extent to which treatment was varied | 76/92 | (82.6) | 87/92 | (94.6) | 12.0 (4.2 to 19.5) |
| Total section A | |||||
| B. Needling details | |||||
| (1) Number of needles | 76/92 | (82.6) | 84/92 | (91.3) | 8.7 (1.9 to 15.5) |
| (2) Names of points | 74/92 | (80.4) | 84/92 | (91.3) | 10.9 (2.7 to 19.0) |
| (3) Depths of insertion | 36/92 | (39.1) | 41/92 | (44.6) | 5.4 (−7.1 to 17.9) |
| (4) Response to needle | 53/92 | (57.6) | 63/92 | (68.5) | 10.9 (0.0 to 21.7) |
| (5) Needle stimulation | 42/92 | (45.7) | 64/92 | (69.6) | 23.9 (13.6 to 34.2) |
| (6) Retention time | 69/92 | (75.0) | 81/92 | (88.0) | 13.0 (4.4 to 21.6) |
| (7) Needle type | 18/92 | (19.6) | 60/92 | (65.2) | 45.7 (34.4 to 56.9) |
| Total section B | |||||
| C. Treatment regimen | |||||
| (1) Number of sessions | 85/92 | (92.4) | 90/92 | (97.8) | 5.4 (−0.3 to 11.2) |
| (2) Frequency/duration | 85/92 | (92.4) | 88/92 | (95.7) | 3.3 (−2.5 to 9.1) |
| Total section C | |||||
| D. Treatment context | |||||
| (1) Details of other treatments | 15/92 | (16.3) | 31/92 | (33.7) | 17.4 (8.6 to 26.2) |
| (2) Setting and context | 2/92 | (2.2) | 19/92 | (20.7) | 18.5 (9.5 to 27.5) |
| Total section D | |||||
| E. Practitioner background | |||||
| (1) Description of acupuncturists | 56/92 | (60.9) | 51/92 | (55.4) | −5.4 (−15.2 to −4.4) |
*Higher number means favourable results to RCTs.
RCTs, randomised controlled trials.